Dr. E.M.W. (Ewoudt) van de Garde

David de Wiedgebouw
Universiteitsweg 99
Kamer 1.09
3584 CG Utrecht

Dr. E.M.W. (Ewoudt) van de Garde

Associate Professor
Pharmacoepi. and Clinical Pharmacol.
+31 6 24 973 097
e.m.w.vandegarde@uu.nl

Publications

2023

Scholarly publications

Chahid, Y., Chahid, F., van de Garde, E., Booij, J., Verberne, H. J., & Hendrikse, N. H. (2023). CYP3A4 inhibitors do not influence [ 68Ga]Ga-DOTA-TATE uptake in liver tissue. EJNMMI Research, 13(1), 84. https://doi.org/10.1186/s13550-023-01034-w
Chahid, Y., Hashimi, K., van de Garde, E. M. W., Klümpen, H-J., Hendrikse, N. H., Booij, J., & Verberne, H. J. (2023). The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors. Clinical Nuclear Medicine, 48(9), 757-762. https://doi.org/10.1097/RLU.0000000000004776
Verschueren, M. V., Dijs, T., Gulikers, J. L., Veelen, A. V., Croes, S., Hendriks, L. E., Smit, A. A., Bloem, L. T., Egberts, A. C., van de Garde, E. M., & Peters, B. J. (2023). Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results. Immunotherapy, 15(11), 839-851. Advance online publication. https://doi.org/10.2217/imt-2023-0002
den Hartog, I., Karu, N., Zwep, L. B., Voorn, G. P., van de Garde, E. M. W., Hankemeier, T., & van Hasselt, J. G. C. (2023). Differential metabolic host response to pathogens associated with community-acquired pneumonia. Metabolism open, 18, 100239. https://doi.org/10.1016/j.metop.2023.100239
Santeon MIBC Study Group (2023). Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer. World Journal of Urology. https://doi.org/10.1007/s00345-023-04408-w
Vis, R., Mathijssen, H., Keijsers, R. G. M., van de Garde, E. M. W., Veltkamp, M., Akdim, F., Post, M. C., & Grutters, J. C. (2023). Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis. Journal of Nuclear Cardiology, 30(4), 1543-1553. Advance online publication. https://doi.org/10.1007/s12350-022-03171-6
Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., der Welle, C. M. C., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., & van de Garde, E. M. W. (2023). Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0). BMC Medical Research Methodology, 23(1), Article 26. https://doi.org/10.1186/s12874-023-01850-7
Mfumbilwa, Z. A., Wilschut, J. A., Simons, M. J. H. G., Ramaekers, B., Joore, M., Retèl, V., der Welle, C. M. C., Schramel, F. M. N. H., van de Garde, E. M. W., & Coupé, V. M. H. (2023). Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands. Scientific Reports, 13(1), Article 2349. https://doi.org/10.1038/s41598-023-29286-5
Adams, H., van de Garde, E. M. W., Vugts, D. J., Grutters, J. C., Oyen, W. J. G., & Keijsers, R. G. (2023). [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial. European Journal of Nuclear Medicine and Molecular Imaging, 50(7), 1929-1939. Advance online publication. https://doi.org/10.1007/s00259-023-06143-1
Wittermans, E., van der Zee, P. A., Qi, H., Grutters, J. C., Voorn, G. P., Bos, W. J. W., van de Garde, E. M. W., & Endeman, H. (2023). Latent class analysis-based subgroups and response to corticosteroids in hospitalised community-acquired pneumonia patients: a validation study. ERJ Open Research, 9(2), Article 00577-2022. https://doi.org/10.1183/23120541.00577-2022
Hackert, M. Q. N., van Uden-Kraan, C. F., Agterof, M. J., van der Velden, A. W. G., Vriens, B. E. P. J., Janssen, J. J. B., Geenen, M., van der Padt-Pruijsten, A., & van de Garde, E. M. W. (2023). Real-world palbociclib effectiveness in patients with metastatic breast cancer: Focus on neutropenia-related treatment modification strategies and clinical outcomes. Cancer Treatment and Research Communications, 35, Article 100691. https://doi.org/10.1016/j.ctarc.2023.100691
Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., Cramer-van der Welle, C. M., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., & van de Garde, E. M. W. (2023). Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC. BMC Medical Research Methodology, 23(1), Article 1. https://doi.org/10.1186/s12874-022-01760-0

Other output

Verschueren, M., Kruik, V., Peters, B., Bloem, L., Bijsmans, A. R., Egberts, T., & van de Garde, E. (2023). Real-world versus clinical trial outcomes of pembrolizumab plus chemotherapy in patients with stage IV non-squamous non-small cell lung cancer. Journal of Thoracic Oncology, 18(4), S72-S72.

2022

Scholarly publications

(S.O.S.MS Consensus Group) (2022). Development of an international, multidisciplinary, patient-centered Standard Outcome Set for Multiple Sclerosis: The S.O.S.MS project. Multiple Sclerosis and Related Disorders, 69, 1-7. Article 104461. https://doi.org/10.1016/j.msard.2022.104461
Santeon NSCLC Study Group (2022). The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer. Cancer Treatment and Research Communications, 34, 1-9. Article 100676. https://doi.org/10.1016/j.ctarc.2022.100676
Wittermans, E., Grutters, J. C., Moeniralam, H. S., Ocak, G., Paul Voorn, G., Bos, W. J. W., & van de Garde, E. M. W. (2022). Overweight and obesity are not associated with worse clinical outcomes in COVID-19 patients treated with fixed-dose 6 mg dexamethasone. International Journal of Obesity, 46(11), 2000-2005. https://doi.org/10.1038/s41366-022-01204-1
https://dspace.library.uu.nl/bitstream/handle/1874/424774/s41366_022_01204_1.pdf?sequence=1
Al Khayat, M. N. M. T., Eijsink, J. F. H., Postma, M. J., van de Garde, E. M. W., & van Hulst, M. (2022). Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups. European Journal of Health Economics, 23(7), 1221-1227. Advance online publication. https://doi.org/10.1007/s10198-021-01422-w
Wittermans, E., van der Zee, P. A., Qi, H., van de Garde, E. M. W., Blum, C. A., Christ-Crain, M., Gommers, D., Grutters, J. C., Voorn, G. P., Bos, W. J. W., & Endeman, H. (2022). Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies. ERJ Open Research, 8(1), 1-11. Article 00489-2021. https://doi.org/10.1183/23120541.00489-2021
TRACE Study investigators (2022). Validation of the PreOperative Score to predict Post-Operative Mortality (POSPOM) in Dutch non-cardiac surgery patients. BMC Anesthesiology, 22(1), 58. Article 58. https://doi.org/10.1186/s12871-022-01564-1
Santeon MIBC Study Group (2022). Hospital variation in treatment patterns and oncological outcomes for patients with muscle-invasive and metastatic bladder cancer in the Netherlands. World Journal of Urology, 40(6), 1469–1479. Advance online publication. https://doi.org/10.1007/s00345-022-03987-4
https://dspace.library.uu.nl/bitstream/handle/1874/422233/s00345_022_03987_4.pdf?sequence=1
Santeon-CAP study group (2022). Neutrophil count, lymphocyte count and neutrophil-to-lymphocyte ratio in relation to response to adjunctive dexamethasone treatment in community-acquired pneumonia. European Journal of Internal Medicine, 96, 102-108. Advance online publication. https://doi.org/10.1016/j.ejim.2021.10.030
https://dspace.library.uu.nl/bitstream/handle/1874/428414/1_s2.0_S095362052100371X_main.pdf?sequence=1
Uitvlugt, E. B., Soeng, D. Y. F., van der Linden, P., & van de Garde, E. M. W. (2022). The dynamics in applied COVID-19 pharmacotherapy and the influence of national guidance in The Netherlands: a quantitative and qualitative study. European Journal of Hospital Pharmacy, 29, e83–e86. Advance online publication. https://doi.org/10.1136/ejhpharm-2021-002781

2021

Scholarly publications

Chahid, Y., Qiu, X., van de Garde, E. M. W., Verberne, H. J., & Booij, J. (2021). Risk factors for nonvisualization of the sentinel lymph node on lymphoscintigraphy in breast cancer patients. EJNMMI Research, 11(1), 1-6. Article 54. https://doi.org/10.1186/s13550-021-00793-8
Den Hartog, I., Zwep, L. B., Vestjens, S. M. T., Harms, A. C., Voorn, G. P., De Lange, D. W., Bos, W. J. W., Hankemeier, T., Van De Garde, E. M. W., & Van Hassel, J. G. C. (2021). Metabolomic profiling of microbial disease etiology in community-acquired pneumonia. PLoS One, 16(6), 1-15. Article e0252378. https://doi.org/10.1371/journal.pone.0252378
Cramer-Van der Welle, C. M., Kastelijn, E. A., Plouvie, B. C., Van Uden-Kraan, C. F., Schramel, F. M. N. H., Groen, H. J. M., & Van de Garde, E. M. W. (2021). Development and evaluation of a real-world outcomes-based tool to support informed clinical decision making in the palliative treatment of patients with metastatic nsclc. JCO clinical cancer informatics, 5, 570-578. https://doi.org/10.1200/CCI.20.00160
Verschueren, M. V., van der Welle, C. M. C., Tonn, M., Schramel, F. M. N. H., Peters, B. J. M., & van de Garde, E. M. W. (2021). The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC. Scientific Reports, 11(1), 1-8. Article 23331. https://doi.org/10.1038/s41598-021-02598-0
de Vries Schultink, A. H. M., Sallevelt, B. T. G. M., Meinders, A. J., van de Garde, E. M. W., & Roescher, N. (2021). The need for gentamicin adjunctive to cefuroxime as empirical sepsis therapy: a local protocol evaluation. Clinical Microbiology and Infection, 27(9), 1354-1355. Advance online publication. https://doi.org/10.1016/j.cmi.2021.03.032
https://dspace.library.uu.nl/bitstream/handle/1874/418810/PIIS1198743X21001671.pdf?sequence=1
for the Santeon MIBC Study Group (2021). Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative. European Urology Open Science, 26, 18-26. https://doi.org/10.1016/j.euros.2021.01.014
The Santeon NSCLC Study Group (2021). Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands. Scientific Reports, 11(1), Article 6306. https://doi.org/10.1038/s41598-021-85696-3
van der Sande, L. J. T. M., Jöbsis, Q., Bannier, M. A. G. E., van de Garde, E. M. W., Coremans, J. J. M., de Vries, F., Dompeling, E., & Driessen, J. H. M. (2021). The risk of community-acquired pneumonia in children using gastric acid suppressants. European Journal of Respiratory Diseases, 58(4), 1-9. Article 2003229. Advance online publication. https://doi.org/10.1183/13993003.03229-2020
Cramer-van der Welle, C. M., Peters, B. J. M., Deenen, M. J., Schramel, F. M. N. H., & van de Garde, E. M. W. (2021). Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014. PharmacoEconomics - Open, 5, 121–127. Advance online publication. https://doi.org/10.1007/s41669-020-00220-z
Marin-Corral, J., Pascual-Guardia, S., Amati, F., Aliberti, S., Masclans, J. R., Soni, N., Rodriguez, A., Sibila, O., Sanz, F., Sotgiu, G., Anzueto, A., Dimakou, K., Petrino, R., van de Garde, E., & Restrepo, M. I. (2021). Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. Chest, 159(1), 58-72. https://doi.org/10.1016/j.chest.2020.06.079
https://dspace.library.uu.nl/bitstream/handle/1874/410838/1_s2.0_S001236922031905X_main.pdf?sequence=1
Sieswerda, E., de Boer, M. G. J., Bonten, M. M. J., Boersma, W. G., Jonkers, R. E., Aleva, R. M., Kullberg, B-J., Schouten, J. A., van de Garde, E. M. W., Verheij, T. J., van der Eerden, M. M., Prins, J. M., & Wiersinga, W. J. (2021). Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clinical Microbiology and Infection, 27(1), 61-66. https://doi.org/10.1016/j.cmi.2020.09.041
Wittermans, E., Vestjens, S. M., Spoorenberg, S. M., Blok, W. L., Grutters, J. C., Janssen, R., Rijkers, G. T., Smeenk, F. W., Voorn, P., van de Garde, E. M., & Bos, W. J. W. (2021). Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: A randomised clinical trial. European Clinical Respiratory Journal, 58(2), 1-10. Article 2002535. Advance online publication. https://doi.org/10.1183/13993003.02535-2020
https://dspace.library.uu.nl/bitstream/handle/1874/418725/2002535.full.pdf?sequence=1
Cramer-van der Welle, C. M., Schramel, F. M. N. H., Peters, B. J. M., van Putten, J. W. G., Klungel, O. H., Groen, H. J. M., & van de Garde, E. M. W. (2021). Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer. Pharmacoepidemiology and Drug Safety, 30(4), 445-450. Advance online publication. https://doi.org/10.1002/pds.5179
https://dspace.library.uu.nl/bitstream/handle/1874/410831/pds.5179.pdf?sequence=1

2020

Scholarly publications

Reesink, D. J., van de Garde, E. M. W., Peters, B. J. M., van der Nat, P. B., Los, M., Horenblas, S., & van Melick, H. H. E. (2020). Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands. Scientific Reports, 10(1), Article 15822. https://doi.org/10.1038/s41598-020-72820-y
Adams, H., Meek, B., van de Garde, E. M., van Moorsel, C. H., Vugts, D. J., Keijsers, R. G., & Grutters, J. C. (2020). Altered splenic [89Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism? American Journal of Nuclear Medicine and Molecular Imaging, 10(4), 168-177. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486548/
https://dspace.library.uu.nl/bitstream/handle/1874/410840/ajnmmi0010_0168.pdf?sequence=1
Daniels, K., van der Nat, P. B., Frequin, S. T. F. M., van der Wees, P. J., Biesma, D. H., Hoogervorst, E. L. J., & van de Garde, E. M. W. (2020). Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis. Multiple Sclerosis International, 2020, Article 5463451. https://doi.org/10.1155/2020/5463451
van de Garde, E. M. W., van Bedaf, L. R., Hurkmans, D. P., & van den Heuvel, M. M. (2020). Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment? Annals of Oncology, 31(12), 1779-1780. https://doi.org/10.1016/j.annonc.2020.09.007
https://dspace.library.uu.nl/bitstream/handle/1874/428417/PIIS0923753420424573.pdf?sequence=1
Vis, R., van de Garde, E. M. W., Meek, B., Korenromp, I. H. E., & Grutters, J. C. (2020). Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis. Respiratory Medicine, 165, Article 105936. https://doi.org/10.1016/j.rmed.2020.105936
https://dspace.library.uu.nl/bitstream/handle/1874/428416/PIIS0954611120300767.pdf?sequence=1
van den Broek, M. P. H., Möhlmann, J. E., Abeln, B. G. S., Liebregts, M., van Dijk, V. F., & van de Garde, E. M. W. (2020). Chloroquine-induced QTc prolongation in COVID-19 patients. Netherlands Heart Journal, 28(7-8), 406-409. https://doi.org/10.1007/s12471-020-01429-7
Cramer-van der Welle, C. M., Schramel, F. M. N. H., van Leeuwen, A. S., Groen, H. J. M., & van de Garde, E. M. W. (2020). Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer. European Journal of Cancer Care, 29(5), 1-6. Article e13250. https://doi.org/10.1111/ecc.13250
Vis, R., van de Garde, E. M. W., Grutters, J. C., & Korenromp, I. H. E. (2020). The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review. European Respiratory Review, 29(155), Article 190057. https://doi.org/10.1183/16000617.0057-2019
Zhang, Z. X., van de Garde, E. M. W., Söhne, M., Harmsze, A. M., & van den Broek, M. P. H. (2020). Quality of clinical Direct Oral Anticoagulants (DOACs) prescribing and identification of risk factors for inappropriate prescriptions. British Journal of Clinical Pharmacology, 86(8), 1567-1574. Advance online publication. https://doi.org/10.1111/bcp.14264
https://dspace.library.uu.nl/bitstream/handle/1874/428415/Brit_J_Clinical_Pharma_2020_Zhang_Quality_of_clinical_direct_oral_anticoagulant_prescribing_and_identification_of.pdf?sequence=1
Révész, D., Engelhardt, E. G., Tamminga, J. J., Schramel, F. M. N. H., Onwuteaka-Philipsen, B. D., van de Garde, E. M. W., Steyerberg, E. W., de Vet, H. C. W., & Coupé, V. M. H. (2020). Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer. Journal of Cancer Education, 35(2), 345-351. https://doi.org/10.1007/s13187-019-1471-8

2019

Scholarly publications

Adams, H., van de Garde, E. M., van Moorsel, C. H., Vugts, D. J., van Dongen, G. A., Grutters, J. C., & Keijsers, R. G. (2019). [89Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study. American Journal of Nuclear Medicine and Molecular Imaging, 9(6), 296-308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971479/
https://dspace.library.uu.nl/bitstream/handle/1874/394682/ajnmmi0009_0296.pdf?sequence=1
Kaldeway, H. P., Ter Borg, E. J., Van De Garde, E. M. W., Habraken, J. B. A., & Van Buul, M. M. C. (2019). Validation of quantitative salivary gland scintigraphy in relation to the American-European concensus criteria for Sjögren's syndrome. Nuclear Medicine Communications, 40(4), 343-348. https://doi.org/10.1097/MNM.0000000000000983
https://dspace.library.uu.nl/bitstream/handle/1874/384891/Validation_of_quantitative.pdf?sequence=1
Bury, D., Ter Heine, R., van de Garde, E. M. W., Nijziel, M. R., Grouls, R. J., & Deenen, M. J. (2019). The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults. European Journal of Clinical Pharmacology, 75, 921–928. https://doi.org/10.1007/s00228-019-02657-6
Wittermans, E., Vestjens, S. M. T., Bos, W. J. W., Grutters, J. C., van de Garde, E. M. W., & Vlaminckx, B. J. M. (2019). The extent of microbiological testing is associated with alteration of antibiotic therapy in adults with community-acquired pneumonia. European Journal of Clinical Microbiology and Infectious Diseases, 38, 1359–1366. https://doi.org/10.1007/s10096-019-03561-8
https://dspace.library.uu.nl/bitstream/handle/1874/394335/Wittermans2019_Article_TheExtentOfMicrobiologicalTest.pdf?sequence=1
Vlot, E. A., Verwijmeren, L., van de Garde, E. M. W., Kloppenburg, G. T. L., van Dongen, E. P. A., & Noordzij, P. G. (2019). Intra-operative red blood cell transfusion and mortality after cardiac surgery. Anesthesiology, 19(1), Article 65. https://doi.org/10.1186/s12871-019-0738-2
Bui, T. B. V., Burgers, D. M., Agterof, M. J., & van de Garde, E. M. (2019). Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy. Breast cancer : basic and clinical research, 13, 1-6. https://doi.org/10.1177/1178223418823238
SWAB’s Working Group on Surveillance of Antimicrobial Use (2019). Consecutive antibiotic use in the outpatient setting: an extensive, longitudinal descriptive analysis of antibiotic dispensing data in the Netherlands. BMC Infectious Diseases, 19(1), Article 84. https://doi.org/10.1186/s12879-019-3732-x
GLIMP Study Group (2019). An international perspective on hospitalized patients with viral community-acquired pneumonia. European Journal of Internal Medicine, 60, 54-70. https://doi.org/10.1016/j.ejim.2018.10.020
https://dspace.library.uu.nl/bitstream/handle/1874/428418/PIIS0953620518304138.pdf?sequence=1
Saleh, M. A. A., van de Garde, E. M. W., & van Hasselt, J. G. C. (2019). Host-response biomarkers for the diagnosis of bacterial respiratory tract infections. Clinical Chemistry and Laboratory Medicine, 57(4), 442-451. https://doi.org/10.1515/cclm-2018-0682
Van De Garde, E. M. W., Plouvier, B. C., Fleuren, H. W. H. A., Haak, E. A. F., Movig, K. L. L., Deenen, M. J., & Van Hulst, M. (2019). Pharmacotherapy within a learning healthcare system: Rationale for the Dutch Santeon Farmadatabase. European Journal of Hospital Pharmacy, 26, 46-50. https://doi.org/10.1136/ejhpharm-2017-001329

2018

Scholarly publications

Vestjens, S. M. T., Wittermans, E., Spoorenberg, S. M. C., Grutters, J. C., van Ruitenbeek, C. A., Voorn, G. P., Bos, W. J. W., & van de Garde, E. M. W. (2018). Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumonia. Pneumonia, 10(15), Article 15. https://doi.org/10.1186/s41479-018-0059-0
Santeon NSCLC Study Group (2018). Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer. European Respiratory Journal, 52(6), Article 1801100. https://doi.org/10.1183/13993003.01100-2018
Smit, C. H., Wiertz-Arts, K., & van de Garde, E. M. (2018). Intravitreal aflibercept versus intravitreal ranibizumab in patients with age-related macular degeneration: a comparative effectiveness study. Comparative Hepatology, 7(6), 561-567. Advance online publication. https://doi.org/10.2217/cer-2017-0099
Lentferink, Y. E., van de Garde, E. M. W., Knibbe, C. A. J., & van der Vorst, M. M. J. (2018). Psychostimulants: Influence on Body Mass Index and Height in a Pediatric Population with Attention-Deficit/Hyperactivity Disorder? Journal of Child and Adolescent Psychopharmacology, 28(8), 530–536. Advance online publication. https://doi.org/10.1089/cap.2017.0163
https://dspace.library.uu.nl/bitstream/handle/1874/428419/cap.2017.0163.pdf?sequence=1
Rottier, W. C., van Werkhoven, C. H., Bamberg, Y. R. P., Dorigo-Zetsma, J. W., van de Garde, E. M., van Hees, B. C., Kluytmans, J. A. J. W., Kuck, E. M., Van Der Linden, P. D., Prins, J. M., Thijsen, S. F. T., Verbon, A., Vlaminckx, B. J. M., Ammerlaan, H. S. M., & Bonten, M. J. M. (2018). Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections: a nested case-control study. Clinical Microbiology and Infection, 24(12), 1315–1321. https://doi.org/10.1016/j.cmi.2018.03.023
https://dspace.library.uu.nl/bitstream/handle/1874/375282/rottier.pdf?sequence=1
Wiersinga, W. J., Bonten, M. J. M., Boersma, W. G., Jonkers, R. E., Aleva, R. M., Kullberg, B-J., Schouten, J. A., Degener, J. E., van de Garde, E. M. W., Verheij, T., Sachs, A. P. E., & Prins, J. M. (2018). Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Netherlands Journal of Medicine, 76(1), 4-13. https://www.ncbi.nlm.nih.gov/pubmed/29380739
https://dspace.library.uu.nl/bitstream/handle/1874/363266/wiersinga.pdf?sequence=1
Rettig, T. C. D., Nijenhuis, V. J., Meek, B., Rigter, S., Ten Berg, J. M., Vlaminckx, B. J. M., van Klei, W. A., van de Garde, E. M. W., Peelen, L. M., & Noordzij, P. G. (2018). Systemic Inflammation after Transcatheter Aortic Valve Implantation: A Prospective Exploratory Study. Journal of Cardiothoracic and Vascular Anesthesia, 32(4), e77-e82. https://doi.org/10.1053/j.jvca.2017.12.051
https://dspace.library.uu.nl/bitstream/handle/1874/375870/inflammation.pdf?sequence=1
de Hoogd, S., Ahlers, S. J. G. M., van Dongen, E. P. A., van de Garde, E. M. W., Daeter, E. J., Dahan, A., Tibboel, D., & Knibbe, C. A. J. (2018). Randomized Controlled Trial on the Influence of Intraoperative Remifentanil versus Fentanyl on Acute and Chronic Pain after Cardiac Surgery. Pain Practice, 18(4), 443-451. https://doi.org/10.1111/papr.12615
Vestjens, S. M. T., Spoorenberg, S. M. C., van de Garde, E. M. W., & Bos, W. J. W. (2018). Inclusion of sepsis and hypoxaemia in mortality prediction of hospitalized patients with community-acquired pneumonia - Reply. Respirology, 23(1), 114-115. Advance online publication. https://doi.org/10.1111/resp.13168
Rettig, T. C. D., Verwijmeren, L., van de Garde, E. M. W., & Noordzij, P. G. (2018). Letter in Response to “No Cytokine is an Island: IL-6 Alone is not Enough to Predict the Morbidity After Major Abdominal Surgery”. Annals of Surgery, 267(2), e32–e33. https://doi.org/10.1097/SLA.0000000000001981
https://dspace.library.uu.nl/bitstream/handle/1874/375850/letter.pdf?sequence=1

2017

Scholarly publications

Peters, B. J. M., Cramer-Vd Welle, C. M., Smit, A. A. J., Schramel, F. M. N. H., van de Garde, E. M. W., & Santeon NSCLC Study Group (2017). Trends in prescribing systemic treatment and overall survival for non-small cell lung cancer stage IIIB/IV in the Netherlands: 2008-2012. Cancer Epidemiology, 51, 1-6. https://doi.org/10.1016/j.canep.2017.08.001
Révész, D., Engelhardt, E. G., Tamminga, J. J., Schramel, F. M. N. H., Onwuteaka-Philipsen, B. D., van de Garde, E. M. W., Steyerberg, E. W., Jansma, E. P., de Vet, H. C. W., & Coupé, V. M. H. (2017). Decision support systems for incurable non-small cell lung cancer: a systematic review. BMC Medical Informatics and Decision Making, 17(1), Article 144. https://doi.org/10.1186/s12911-017-0542-1
van de Garde, E. M. W., van Wessel, T., Teeuwisse, A. K., & Steenman, S. C. (2017). Selectie of 'gewongen matching' in de master: Identificeren van instrumenten die studiesucces kunnen voorspellen bij Farmacie. Onderzoek van Onderwijs, 46(2), 8-12. https://www.tijdschriftovo.nl/art/50-4615_Selectie-of-gedwongen-matching-in-de-master-identificeren-van-instrumenten-die-studiesucces-kunnen-voorspellen-bij-Farmacie
Spoorenberg, S. M. C., Vestjens, S. M. T., Rijkers, G. T., Meek, B., van Moorsel, C. H. M., Grutters, J. C., Bos, W. J. W., Biesma, D. H., Endeman, H., van de Garde, E. M. W., Hardeman, H., Heijligenberg, R., Meijvis, S. C. A., Remmelts, H. H. F., van Velzen-Blad, H., Voorn, P. G. P., & Ovidius Study Group (2017). YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia. Respirology, 22(3), 542-550. https://doi.org/10.1111/resp.12924
https://dspace.library.uu.nl/bitstream/handle/1874/356010/19.pdf?sequence=1
Rettig, T. C. D., Vermeulen, E., Dijkstra, I. M., van Klei, W. A., Van De Garde, E. M. W., Peelen, L. M., & Noordzij, P. G. (2017). Intraoperative hypotension and change in estimated glomerular filtration rate after major abdominal surgery. European Journal of Anaesthesiology, 34(4), 243-246. https://doi.org/10.1097/EJA.0000000000000540
https://dspace.library.uu.nl/bitstream/handle/1874/356009/18.pdf?sequence=1
Vestjens, S. M. T., Wagenvoort, G. H. J., Grutters, J. C., Meek, B., Aldenkamp, A. F., Vlaminckx, B. J. M., Bos, W. J. W., Rijkers, G. T., & van de Garde, E. M. W. (2017). Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands. Vaccine, 35(33), 4112-4118. https://doi.org/10.1016/j.vaccine.2017.06.049
https://dspace.library.uu.nl/bitstream/handle/1874/356008/Changes.pdf?sequence=1
Rettig, T. C. D., Peelen, L. M., Geuzebroek, G. S. C., van Klei, W. A., Boer, C., van der Veer, J. W., Hofland, J., van de Garde, E. M. W., & Noordzij, P. G. (2017). Impact of Intraoperative Hypotension During Cardiopulmonary Bypass on Acute Kidney Injury After Coronary Artery Bypass Grafting. Journal of Cardiothoracic and Vascular Anesthesia, 31(2), 522-528. https://doi.org/10.1053/j.jvca.2016.07.040
https://dspace.library.uu.nl/bitstream/handle/1874/356007/17.pdf?sequence=1
Vestjens, S. M. T., Spoorenberg, S. M. C., Rijkers, G. T., Grutters, J. C., ten Berg, J. M., Noordzij, P. G., Van de Garde, E. M. W., Bos, W. J. W., Biesma, D. H., Endeman, H., Hardeman, H., Heijligenberg, R., Meijvis, S. C. A., Remmelts, H. H. F., van Velzen-Blad, H., Voorn, P. G. P., & the Ovidius Study Group (2017). High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia. Respirology, 22(5), 1000-1006. https://doi.org/10.1111/resp.12996
https://dspace.library.uu.nl/bitstream/handle/1874/356006/High.pdf?sequence=1
van Werkhoven, C. H., van de Garde, E. M. W., Oosterheert, J. J., Postma, D. F., & Bonten, M. J. M. (2017). Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy. Respiratory Medicine, 129, 145-151. https://doi.org/10.1016/j.rmed.2017.06.012
https://dspace.library.uu.nl/bitstream/handle/1874/356005/Atypical.pdf?sequence=1
Koster, E. S., Schmidt, A., Philbert, D., van de Garde, E. M. W., & Bouvy, M. L. (2017). Health literacy of patients admitted for elective surgery. Journal of Public Health , 25(2), 181-186. https://doi.org/10.1007/s10389-016-0774-z

Professional publications

Koster, E. S., Schmidt, A., Philbert, D., van de Garde, E. M. W., & Bouvy, M. L. (2017). Beperkte gezondheidsvaardigheden vormen risico bij ziekenhuisopname: Ruim helft patiënten heeft moeite met complexe gezondheidsbeslissingen. Pharmaceutisch Weekblad, 152(4), 18-19. https://www.pw.nl/achtergrond/2017/beperkte-gezondheidsvaardigheden-vormen-risico-bij-ziekenhuisopname

2016

Scholarly publications

van der Aa, M. P., Elst, M. A. J., van de Garde, E. M. W., van Mil, E. G. A. H., Knibbe, C. A. J., & van der Vorst, M. M. J. (2016). Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial. Nutrition & diabetes, 6(8), Article e228. https://doi.org/10.1038/nutd.2016.37
Rettig, T. C. D., Verwijmeren, L., Noordzij, P. G., van de Garde, E. M. W., & Boerma, D. (Accepted/In press). Biomarkers Capable to Early Predict Postoperative Complications: The Grail. Annals of Surgery. https://doi.org/10.1097/SLA.0000000000001774
Vlot, E. A., Meents, N., van de Garde, E. M. W., Hackeng, C. M., & Noordzij, P. G. (2016). Early Point-of-Care Platelet Function Testing Using Multiple Electrode Aggregometry in Patients Undergoing Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia, 30(6), e56-e58. https://doi.org/10.1053/j.jvca.2016.05.017
https://dspace.library.uu.nl/bitstream/handle/1874/356192/1.pdf?sequence=1
van der Aa, M. P., Hoving, V., van de Garde, E. M. W., de Boer, A., Knibbe, C. A. J., & van der Vorst, M. M. J. (2016). The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial. Journal of Obesity, 2016, Article 7852648. https://doi.org/10.1155/2016/7852648
Rettig, T. C. D., Verwijmeren, L., Dijkstra, I. M., Boerma, D., Van De Garde, E. M. W., & Noordzij, P. G. (2016). Postoperative interleukin-6 level and early detection of complications after elective major abdominal surgery. Annals of Surgery, 263(6), 1207-1212. https://doi.org/10.1097/SLA.0000000000001342
https://dspace.library.uu.nl/bitstream/handle/1874/336994/00000658_201606000_00030.pdf?sequence=1
de Jong, E., van Oers, J. A., Beishuizen, A., Vos, P., Vermeijden, W. J., Haas, L. E., Loef, B. G., Dormans, T., van Melsen, G. C., Kluiters, Y. C., Kemperman, H., van den Elsen, M. J., Schouten, J. A., Streefkerk, J. O., Krabbe, H. G., Kieft, H., Kluge, G. H., van Dam, V. C., van Pelt, J., ... de Lange, D. W. (2016). Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: A randomised, controlled, open-label trial. The Lancet Infectious Diseases, 16(7), 819-827. https://doi.org/10.1016/S1473-3099(16)00053-0
https://dspace.library.uu.nl/bitstream/handle/1874/336993/1_s2.0_S1473309916000530_main.pdf?sequence=1
Peters, B. J. M., Janssen, V. E. M. T., Schramel, F. M., & van de Garde, E. M. W. (2016). Quantitative and qualitative assessment of real world data comparative effectiveness research of systemic therapies in lung oncology: A systematic review. Cancer Epidemiology, 44, 5-15. https://doi.org/10.1016/j.canep.2016.07.005
https://dspace.library.uu.nl/bitstream/handle/1874/336992/1_s2.0_S1877782116300911_main.pdf?sequence=1
Raeven, V. M., Spoorenberg, S. M. C., Boersma, W. G., van de Garde, E. M. W., Cannegieter, S. C., Voorn, G. P. P., Bos, W. J. W., van Steenbergen, J. E., & Alkmaar study group (2016). Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infectious Diseases [E], 16(1), Article 299. https://doi.org/10.1186/s12879-016-1641-9
Noordzij, P. G., Rettig, T. C. D., van de Garde, E. M. W., & van Dongen, E. P. A. (2016). Letter in response to 'Testing the limits: high-sensitivity cardiac troponin in the prediction of non-cardiac complications after major abdominal surgery'. British Journal of Anaesthesia, 116(2), 305-306. https://doi.org/10.1093/bja/aev475
https://dspace.library.uu.nl/bitstream/handle/1874/329899/305.2.full.pdf?sequence=1
Vis, R., Malviya, G., Signore, A., Grutters, J. C., Meek, B., van de Garde, E. M. W., & Keijsers, R. G. M. (2016). 99mTc-anti-TNF-α antibody for the imaging of disease activity in pulmonary sarcoidosis. European Respiratory Journal, 47, 1198-1207. https://doi.org/10.1183/13993003.01352-2015
https://dspace.library.uu.nl/bitstream/handle/1874/428421/1198.full.pdf?sequence=1
Banser, A., Naafs, J. C., Hoorweg-Nijman, J. J., van de Garde, E. M., & van der Vorst, M. M. (2016). Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus. Pediatric Diabetes, 17(6), Article 426-432. Advance online publication. https://doi.org/10.1111/pedi.12311
https://dspace.library.uu.nl/bitstream/handle/1874/428422/Pediatric_Diabetes_2015_Banser_Advanced_glycation_end_products_measured_in_skin_vs_HbA1c_in_children_with_type_1.pdf?sequence=1

2015

Scholarly publications

de Hoogd, S., Ahlers, S. J. G. M., van Dongen, E. P. A., van de Garde, E. M. W., Hamilton-ter Brake, A. T., Dahan, A., Tibboel, D., & Knibbe, C. A. J. (Accepted/In press). Is Intraoperative Remifentanil Associated With Acute or Chronic Postoperative Pain After Prolonged Surgery? An Update of the Literature. Clinical Journal of Pain. https://doi.org/10.1097/AJP.0000000000000317
Van De Garde, E. M. W., Natsch, S., Prins, J. M., & Van Der Linden, P. D. (2015). Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment: A cohort study on clinical outcome. BMJ Open, 5(2), Article e006892. https://doi.org/10.1136/bmjopen-2014-006892
Rettig, T. C. D., Rigter, S., Nijenhuis, V. J., Van Kuijk, J. P., Ten Berg, J. M., Heijmen, R. H., Van De Garde, E. M. W., & Noordzij, P. G. (2015). The systemic inflammatory response syndrome predicts short-term outcome after transapical transcatheter aortic valve implantation. Journal of Cardiothoracic Vascular Anesthesia, 29(2), 283-287. https://doi.org/10.1053/j.jvca.2014.10.005
https://dspace.library.uu.nl/bitstream/handle/1874/320076/systemic.pdf?sequence=1
Vestjens, S. M. T., Spoorenberg, S. M. C., Rijkers, G. T., Grutters, J. C., Van De Garde, E. M. W., Meijvis, S. C. A., & Bos, W. J. W. (2015). Antipyretic effect of dexamethasone in community-acquired pneumonia. European Respiratory Journal, 46(2), 570-573. https://doi.org/10.1183/09031936.00224814
https://dspace.library.uu.nl/bitstream/handle/1874/320075/Antipyretic.pdf?sequence=1
Noordzij, P. G., van Geffen, O., Dijkstra, I. M., Boerma, D., Meinders, A. J., Rettig, T. C. D., Eefting, F. D., van Loon, D., van de Garde, E. M. W., & van Dongen, E. P. A. (2015). High-sensitive cardiac troponin T measurements in prediction of non-cardiac complications after major abdominal surgery. British Journal of Anaesthesia, 114(6), 909-918. https://doi.org/10.1093/bja/aev027
https://dspace.library.uu.nl/bitstream/handle/1874/320074/high_sensitive.pdf?sequence=1
Vis, R., Lavalaye, J., & van de Garde, E. M. W. (2015). GMP-compliant <sup>68</sup>Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use. EJNMMI research [E], 5(1), 1-7. https://doi.org/10.1186/s13550-015-0105-3

2014

Scholarly publications

Spoorenberg, S. M. C., Deneer, V. H. M., Grutters, J. C., Pulles, A. E., Voorn, G. P., Rijkers, G. T., Bos, W. J. W., & Van De Garde, E. M. W. (2014). Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. British Journal of Clinical Pharmacology, 78(1), 78-83. https://doi.org/10.1111/bcp.12295
de Groot, M. C. H., Klungel, O. H., Leufkens, H. G. M., van Dijk, L., Grobbee, D. E., & van de Garde, E. M. W. (2014). Sources of heterogeneity in case–control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia. European Journal of Epidemiology, 29(10), 767-775. https://doi.org/10.1007/s10654-014-9941-0
Hartholt, N. L., Rettig, T. C. D., Schijffelen, M., Morshuis, W. J., van de Garde, E. M. W., & Noordzij, P. G. (2014). Preoperative statin therapy and infectious complications in cardiac surgery. Netherlands Heart Journal, 22(11), 503-9. https://doi.org/10.1007/s12471-014-0581-5
Spoorenberg, S. M. C., Deneer, V. H. M., Grutters, J. C., Pulles, A. E., Voorn, G. P., Rijkers, G. T., Bos, J. W. J., & van de Garde, E. M. W. (2014). Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-aquired pneumonia. British Journal of Clinical Pharmacology, 78(1), 78-83.
Spoorenberg, S. M. C., Bos, W. J., Heijligenberg, R., Voorn, G. P., Grutters, J. C., Rijkers, G. T., & van de Garde, E. M. W. (2014). Microbial aetiology, outcomes, and costs of hospitalisation for community-aquired pneumonia; an observational analysis. BMC Infectious Diseases [E], 14, 335.

2013

Scholarly publications

Remmelts, H. H. F., Spoorenberg, S. M. C., Oosterheert, J. J., Bos, W. J. W., De Groot, M. C. H., & Van De Garde, E. M. W. (2013). The role of vitamin D supplementation in the risk of developing pneumonia: Three independent case-control studies. Thorax, 68(11), 990-996. https://doi.org/10.1136/thoraxjnl-2013-203623
Peters, B. J. M., Capelle, M. A., Arvinte, T., & van de Garde, E. M. W. (2013). Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (inlfiximab) and Herceptin (trastuzumab). mAbs, 5(1), 162-170.

Other output

De Groot, M. C. H., Klungel, O. H., Leufkens, H. G. M., Van Dijk, L., Grobbee, D. E., & Van De Garde, E. M. W. (2013). Multiple database approach for study of associations between frequently used drugs and community-acquired pneumonia. Pharmacoepidemiology and Drug Safety, 22(s1), 289. Article 584. https://doi.org/10.1002/pds.3512

2012

Scholarly publications

Gulik, L., Ahlers, S. J., van de Garde, E. M. W., Bruins, P., van Boven, W. J., Tibboel, D., van Dongen, E. P. A., & Knibbe, C. A. J. (2012). Remifentanil during cardiac surgery is associated with chronic thoracic pain 1 yr after sternotomy. Br J Anaesth, 109(4), 616-22.
Meijvis, S. C. A., van de Garde, E. M. W., Rijkers, G. T., & Bos, W. J. W. (2012). Treatment with anti-inflammatory drugs in community-acquired pneumonia. Journal of Internal Medicine, 272, 25-35.
Ahlers, S. J., Gulik, L., van Dongen, E. P. A., Bruins, P., van de Garde, E. M. W., van Boven, W. J., Tibboel, D., & Knibbe, C. A. J. (2012). Efficacy of an intravenous bolus of morphine 2.5 versus morphine 7.5 mg for procedural pain relief in postoperative cardiothoracic patients in the intensive care unit: a randomised double-blind controlled trial. Anaesth Intensive Care, 40(3), 417-26. http://cat.inist.fr/?aModele=afficheN&cpsidt=25924041
Remmelts, H. H. F., van de Garde, E. M. W., Meijvis, S. C. A., Peelen, E., Damoiseaux, J., Grutters, J. C., Biesma, D. H., Bos, W. J. W., & Rijkers, G. T. (2012). Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clinical Infectious Diseases, 55(11), 1488-1494. http://www.ncbi.nlm.nih.gov/pubmed/22942205

2011

Scholarly publications

van den Hoek, H. L., Bos, W. J. W., de Boer, A., & van de Garde, E. M. W. (2011). Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials. BMJ - Clinical research, 343, d7281.
Meijvis, S. C. A., Cornips, M. C., Endeman, H., Ruven, H. J. T., Danser, A. H. J., Biesma, D. H., Leufkens, H. G. M., Bos, W. J., & van de Garde, E. M. W. (2011). Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine, 49(9), 1525-1532.
Meijvis, S. C. A., Cornips, M. C., Voorn, G. P., Souverein, P. C., Endeman, H., Biesma, D. H., Leufkens, H. G. M., & van de Garde, E. M. W. (2011). Microbial evaluation of proton-pump inhibitors and the risk of pneumonia. European Respiratory Journal, 38(5), 1165-1172.
van Kralingen, S., Taks, M., Diepstraten, J., van de Garde, E. M., van Dongen, E. P., Wiezer, M. J., van Ramshorst, B., Vlaminckx, B., Deneer, V. H., & Knibbe, C. A. (2011). Pharmacokinetics and protein binding of cefazolin in morbidly obese patients. European Journal of Clinical Pharmacology, 67(10), 985-92. https://doi.org/10.1007/s00228-011-1048-x
Meijvis, S. C. A., Hardeman, H. H., Remmelts, H. H. F., Heijligenberg, R., Rijkers, G. T., van Velzen-Blad, H., Voorn, G. P., van de Garde, E. M. W., Endeman, H., Grutters, J. C., Bos, W. J., & Biesma, D. H. (2011). Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. The Lancet, 377(9782), 2023-2030. http://www.ncbi.nlm.nih.gov/pubmed/21636122
van Kralingen, S., van de Garde, E. M. W., Knibbe, C. A. J., Diepstraten, J., Wiezer, M. J., van Ramshorst, B., & van Dongen, E. P. A. (2011). Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients. British Journal of Clinical Pharmacology, 71(1), 34-40. https://doi.org/10.1111/j.1365-2125.2010.03803.x
van Kralingen, S., van de Garde, E. M. W., van Dongen, E. P. A., Diepstraten, J., Deneer, V. H. M., van Ramshorst, B., & Knibbe, C. A. J. (2011). Maintenance of anesthesia in morbidly obese patients using propofol with continuous BIS-monitoring: a comparison of propofol-remifentanil and propofol-epidural anesthesia. Acta Anaesthesiol Belg, 62(2), 73-82.
Keijsers, R. G. M., Verzijlbergen, F. J., van den Bosch, J. M. M., Zanen, P., van de Garde, E. M. W., Oyen, W. J., & Grutters, J. C. (2011). 18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 28(2), 123-129.

2010

Scholarly publications

van Kralingen, S., Diepstraten, J., van de Garde, E. M. W., van der Lely, A. J., van Dongen, E. P. A., van Ramshorst, B., & Knibbe, C. A. J. (2010). Comparative evaluation of propofol 350 and 200 mg for induction of anaesthesia in morbidly obese patients: a randomized double-blind pilot study. Eur J Anaesthesiol, 27(6), 572-4.

2009

Scholarly publications

Lavalaye, J., Grutters, J. C., van de Garde, E. M. W., van Buul, M. M. C., van den Bosch, J. M. M., Windhorst, A. D., & Verzijlbergen, F. J. (2009). Imaging of fibrogenesis in patients with idiopathic pulmonary fibrosis with cis-4-[(18)F]-Fluoro-L: -proline PET. Molecular Imaging and Biology, 11(2), 123-7.

Professional publications

Boom, F., van de Garde, E. M. W., & Vries, P. A. (2009). Sterilisatiemethoden. In Y. Bouwman-Boer, P. Le Brun, C. Oussoren, & H. Woerdenbach (Eds.), Recepteerkunde Bohn Stafleu van Loghum.

2008

Scholarly publications

Van De Garde, E. M. W., Endeman, H., Van Hemert, R. N., Voorn, G. P., Deneer, V. H. M., Leufkens, H. G. M., Van Den Bosch, J. M. M., & Biesma, D. H. (2008). Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: Hospital-based study. European Journal of Clinical Pharmacology, 64(4), 405-410. https://doi.org/10.1007/s00228-007-0407-0
van de Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., A Sayed-Tabatabaei, F., Ruven, H. J. T., Leufkens, H. G. M., & van den Bosch, J. M. M. (2008). Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia. Chest, 133, 220-225.
https://dspace.library.uu.nl/bitstream/handle/1874/32219/garde_08_angiotensinconvertingenzymeInsertion.pdf?sequence=1

Professional publications

van de Garde, E. M. W., Endeman, H., van Hemert, R. N., Voorn, G. P., Deneer, V. H. M., Leufkens, H. G. M., van den Bosch, J. M. M., & Biesma, D. H. (2008). Antibioticagebruik voor ziekenhuisopname voorspelt microbiologische etiologie van pneumonie. Pharmaceutisch Weekblad, 20, 109-111.
van de Garde, E. M. W. (2008). Statines ter preventie van pneunomie. Huisarts en Wetenschap, 51, 195-197.

Other output

van de Garde, E. M. W., Deneer, V. H. M., Souverein, P. C., van den Bosch, J. M. M., & Leufkens, H. G. M. (2008). Validation of Community-Acquired Pneumonia: High Postitive Predictive Value for ICD-9 Codes. S248. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.

2007

Scholarly publications

Van De Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., Ruven, H. J. T., Van Velzen-Blad, H., Leufkens, H. G. M., & Van Den Bosch, J. M. M. (2007). Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine, 45(10), 1326-1331. https://doi.org/10.1515/CCLM.2007.268
van de Garde, E. M. W. (2007). Drug effects on the risk and prognosis of community-acquired pneumonia. [Doctoral thesis 1 (Research UU / Graduation UU), Utrecht University].
van de Garde, E. M. W., Souverein, P. C., Hak, E., Deneer, V. H. M., van den Bosch, J. M. M., & Leufkens, H. G. M. (2007). Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. Journal of Hypertension, 25(1), 235-239. https://doi.org/10.1097/HJH.0b013e328010520a
https://dspace.library.uu.nl/bitstream/handle/1874/27357/garde_07_angiotensinconvertingenzyme.pdf?sequence=1
van de Garde, E. M. W., Oosterheert, J. J., Bonten, M. J. M., Kaplan, R. C., & Leufkens, H. G. M. (2007). International classification of diseases codes showed modest sensitivity for detecting community-aquired pneumonia. Journal of Clinical Epidemiology, 60(8), 834-838.
https://dspace.library.uu.nl/bitstream/handle/1874/27382/garde_07_internationalclassificationofdiseasescodes.pdf?sequence=1
van de Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., Ruven, H. J. T., van Velzen-Blad, H., Leufkens, H. G. M., & van den Bosch, J. M. M. (2007). Angiotensin-converting enzyme (ACE) I/D corected serum ACE activity and severity assessment of community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine, 45(10), 1326-1331.
https://dspace.library.uu.nl/bitstream/handle/1874/27391/garde_07_angiotensinconvertingenzyme.pdf?sequence=1

Other output

van de Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., & A Sayed-Tabatabaei, F. (2007). Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia. S171. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.

2006

Scholarly publications

van de Garde, E. M. W., Souverein, P. C., van den Bosch, J. M. M., Deneer, V. H. M., & Leufkens, H. G. M. (2006). Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. European Respiratory Journal, 27(6), 1217-1222. https://doi.org/10.1183/09031936.06.00110005
van de Garde, E. M. W., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M. M., & Leufkens, H. G. M. (2006). Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax, 61(11), 957-961.
https://dspace.library.uu.nl/bitstream/handle/1874/27346/garde_06_statintreatmentandreducedrisk.pdf?sequence=1
van de Garde, E. M. W., Souverein, P. C., van den Bosch, J. M. M., Deneer, V. H. M., Goettsch, W. G., & Leufkens, H. G. M. (2006). Prior outpatient antibacterial therapy as prognostic factor for mortality in hospitalized pneumonia patients. Respiratory Medicine, 100(8), 1342-1348. https://doi.org/10.1016/j.rmed.2005.11.024
van de Garde, E. M. W., Bras, L. J., Heijmen, R. H., Knibbe, C. A. J., van Dongen, E. P. A., Wiltink, E. H. H., & Biesma, D. H. (2006). Low-Dose Recombinant Factor VIIa in the Management of Uncontrolled Postoperative Hemorrhage in Cardiac Surgery Patients. Journal of Cardiothoracic Vascular Anesthesia, 20(4), 573-575.
https://dspace.library.uu.nl/bitstream/handle/1874/27339/garde_06_lowdoserecombinantfactorviia.pdf?sequence=1

Other output

van de Garde, E. M. W., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M. M., & Leufkens, H. G. M. (2006). Statin Therapy and Reduced Risk of Pneumonia in Elderly Patients with Diabetes. S47. Abstract from Unknown event, Asilomar, USA.

2005

Professional publications

Van De Garde, E. M. W., & Tjoeng, M. M. (2005). Status klinische farmacie als onderdeel electronisch patientendossier. Pharmaceutisch Weekblad, 140(46), 1461-1464.

Other output

van de Garde, E. M. W., van den Bosch, J. M. M., Deneer, V. H. M., Souverein, P. C., & Leufkens, H. G. M. (2005). Use of ACE-Inhibitors and Risk of Community-Acquired Pneumonia. S135. Abstract from Unknown event, Asilomar, USA.

2004

Professional publications

Van De Garde, E. M. W. (2004). Geneesmiddel als diagnosticus. Pharmaceutisch Weekblad, 139(34), 1084.